Fecal microbiota tx feasible for recurrent C. difficile in HIV

May 22, 2013
Fecal microbiota tx feasible for recurrent <i>C. difficile</i> in HIV
For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.

(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.

Latesha Elopre, M.D., and Martin Rodriguez, M.D., from the University of Alabama at Birmingham, describe two cases of fecal microbiota therapy in HIV-infected individuals—a 48-year-old man with AIDS receiving highly-active antiretroviral therapy and a 48-year- old woman with and AIDS receiving highly-active antiretroviral therapy. The first patient presented with recurrent diarrhea for eight months secondary to C. difficile infection and consented to fecal microbiota therapy after five relapses. The second patient was hospitalized for recurrent C. difficile infection and consented to fecal therapy after repeated recurrences following discontinuation of vancomycin therapy.

The researchers found that the day after administration of the the diarrhea and abdominal pain resolved for the first patient, and the diarrhea decreased for the second patient. During five years of follow-up, the first patient experienced no recurrences, while the second patient had no further recurrences during six weeks of follow-up.

"On the basis of our experience, we believe that fecal microbiota therapy should be considered in other HIV-infected patients who have recurrent episodes of C. difficile infection that do not respond to standard therapy," the authors write.

One author disclosed to Merck.

Explore further: Fecal microbiota transplants effective treatment for C. difficile, Inflammatory Bowel Disease

More information: Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.